Lumicell Receives FDA Approval for LUMISIGHT™ and Lumicell™ Direct Visualization System, Revolutionizing Breast Cancer Surgery

LUMISIGHT™ and Lumicell™ Direct Visualization System (DVS) offer 84% diagnostic accuracy in detecting residual cancer, in real-time, that may h...

April 18, 2024 | Thursday | News
GE HealthCare Launches Voluson Signature 20 and 18 Ultrasound Systems Revolutionizing Women's Health Diagnosis

GE HealthCare announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which comprehensively integrate artificial intelligence (AI), adv...

April 18, 2024 | Thursday | News
DoseMe Expands Global Footprint as Premier Hospitals and Cancer Centers across Australia Continue to Adopt Bayesian Dosing

    -DoseMe, a leading provider of model-informed precision dosing (MIPD) software, is pleased to announce the continued growth in Au...

April 17, 2024 | Wednesday | News
QIAGEN Introduces NeuMoDx HIV-1 Quant Assay in Thailand for Blood-Borne Virus Testing

QIAGEN has announced the approval of its NeuMoDx human immunodeficiency virus type 1 (HIV-1) assay for use in Thailand. This approval completes the suite o...

April 15, 2024 | Monday | News
UroGen Pharma Plans Phase 3 Study for UGN-103, a Promising Treatment for Bladder Cancer

  UroGen plans to initiate a Phase 3 study to explore the safety and efficacy of UGN-103 in 2024 Anticipated advantages include a new 80 mg mi...

April 15, 2024 | Monday | News
Agilent Technologies' GenetiSure Dx Postnatal Assay Earns European IVDR Class C Certification

Agilent Technologies Inc.  announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification demon...

April 15, 2024 | Monday | News
EFA Technologies Launches Operations in Brazil with Revolutionary Portable Blood Lab

This expansion comes in the wake of regulatory approval granted last October by Anvisa, the Brazilian health regulatory authority, for EFA's groundbreaking...

April 10, 2024 | Wednesday | News
OM1 and Medtronic Collaborate on Study Demonstrating Reduced Healthcare Resource Use with PROPEL Devices in Sinus Surgery

-OM1, the leading AI and insights-driven technology and data company specializing in personalized medicine, evidence generation, and real-world evidence, t...

April 09, 2024 | Tuesday | News
GE HealthCare Introduces Caption AI for Vscan Air SL Ultrasound System, Enhancing Cardiac Care Accessibility

GE HealthCare (Nasdaq: GEHC) announces a groundbreaking advancement in cardiac care with the launch of Caption AI artificial intelligence (AI)-driven softw...

April 04, 2024 | Thursday | News
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders

  Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company specializing in allosteric modulation-based drug development,...

April 03, 2024 | Wednesday | News
Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia

Incyte and China Medical System Holdings Limited  are pleased to announce that on March 31, 2024, Incyte and CMS, through a wholly-owned dermatology m...

April 02, 2024 | Tuesday | News
Align Technology Launches Invisalign® Palatal Expander System in Australia and New Zealand

Invisalign® Palatal Expanders offer doctors an effective and easily removable alternative to traditional palatal expanders, without the need for meta...

April 02, 2024 | Tuesday | News
Key Proteo Advances Early Detection of Rare Genetic Disorders with FDA Submission of Newborn Screening Kit

Key Proteo, a pioneering proteomics diagnostics company specializing in the enhanced early detection of rare but treatable genetic disorders, today announc...

April 01, 2024 | Monday | News
Maverix Medical Acquires Cirrus Bio to Spearhead Lung Cancer Diagnostics, Establishes Maverix Dx Division

Maverix Medical, a dedicated lung cancer platform established by Ajax Health, KKR, and Hologic, Inc.,  announced the acquisition of Cirrus Bio for an ...

April 01, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close